Education
About Us
Working with TipRanks
Follow Us
Anagenics Limited (AU:AN1)
ASX:AN1
AN1 Stock Chart & Stats
Currently, no data available
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
Volume93.85K
Average Volume (3M)N/A
Market Cap
AU$3.69M
Enterprise ValueN/A
Total Cash (Recent Filing)AU$471.13K
Total Debt (Recent Filing)AU$628.73K
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Aug 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)1.64
Price to Sales (P/S)N/A
P/FCF Ratio-1.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Anagenics News
PremiumCompany Announcements
Anagenics’ Haircare Innovation: Bouf’s Successful Launch
PremiumCompany Announcements
Anagenics Director Increases Shareholding
PremiumCompany Announcements
Anagenics Director Increases ShareholdingPremiumCompany Announcements
Anagenics Director Increases Shareholding
PremiumCompany Announcements
Anagenics Director Increases Shareholdings, Signaling Confidence
PremiumCompany Announcements
Anagenics Director Increases Shareholding
PremiumCompany Announcements
Anagenics Limited to Resume Trading on ASXPremiumCompany Announcements
Anagenics Limited Outlines Strategic Growth Plans Post-RestructuringOptions Prices
Currently, No data available
---
Ownership Overview
1.82% Insiders
―
Mutual Funds
― Other Institutional Investors
98.18% Public Companies and
Individual Investors
AN1 FAQ
What was Anagenics Limited’s price range in the past 12 months?
Currently, no data Available
What is Anagenics Limited’s market cap?
Anagenics Limited’s market cap is AU$3.69M.
When is Anagenics Limited’s upcoming earnings report date?
Anagenics Limited’s upcoming earnings report date is Aug 28, 2025 which is in 77 days.
How were Anagenics Limited’s earnings last quarter?
Anagenics Limited released its earnings results on Feb 27, 2025. The company reported -AU$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.001.
Is Anagenics Limited overvalued?
According to Wall Street analysts Anagenics Limited’s price is currently Overvalued.
Does Anagenics Limited pay dividends?
Anagenics Limited does not currently pay dividends.
What is Anagenics Limited’s EPS estimate?
Anagenics Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Anagenics Limited have?
Currently, no data Available
What happened to Anagenics Limited’s price movement after its last earnings report?
Anagenics Limited reported an EPS of -AU$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Anagenics Limited?
Currently, no hedge funds are holding shares in AU:AN1
Anagenics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
AU:AN1 Sentiment 67%
Sector Average 63%
Sector Average 63%
Insider Transactions
Bought Shares
Worth AU$34.9K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Fundamentals
Return on Equity
-135.49%
Trailing 12-Months
Asset Growth
-61.98%
Trailing 12-Months
Company Description
Anagenics Limited
Anagenics Limited operates as a health and beauty-tech company in Australia, New Zealand, Japan, and internationally. The company develops and sales FGF5 inhibitor hair health and hair growth products under the evolis, evolis Professional, Lexilis Hybrid, Jo-Ju RED, and Lexilis BLACK brands. It markets its products through various channels, including e-commerce, television shopping, wholesale pharmacy and salons, and cross border export markets. The company was formerly known as Cellmid Limited and changed its name to Anagenics Limited in December 2021. Anagenics Limited was incorporated in 2004 and is based in Sydney, Australia.